Hansa Biopharma has strengthened its commercial leadership by appointing Maria Törnsén as Chief Operating Officer and President US. This strategic move comes ahead of key milestones for its kidney transplant drug Idefirix.
Who to call at Hansa Biopharma, and when
A new leader at Hansa Biopharma brings new priorities and often new vendors. The first weeks are when they listen.
An alert the day Hansa Biopharma raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Hansa Biopharma, from your own LinkedIn network
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
Hansa Biopharma
Location
Lund, Skåne County, Sweden
About
Hansa Biopharma, is a pioneering commercial-stage biopharmaceutical company on a mission to develop and commercialize innovative and life altering treatments for patients with rare immunological conditions.
Hansa scientists are working on developing immunomodulatory treatments for organ transplants, rare IgG-mediated autoimmune conditions, and gene therapy, as well as exploring the potential application of the technology platform in oncology.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Hansa Biopharma changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
LundBiotechnologyHealth CareMedicalTherapeuticsBiopharma